Loteprednol / Tobramycin Ophthalmic Dosage
Medically reviewed by Drugs.com. Last updated on Nov 18, 2024.
Applies to the following strengths: 0.5%-0.3%
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Uveitis
Apply 1 or 2 drops into the conjunctival sac of the affected eye(s) every 4 to 6 hours; during the initial 24 to 48 hours, may increase frequency to every 1 to 2 hours
Comments:
- The frequency should be gradually decreased as warranted by improvement of clinical signs.
- Care should be taken as to not discontinue therapy prematurely.
- A maximum of 20 mL should be prescribed initially and not refilled without further evaluation.
Use: For the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or risk of bacterial ocular infection exists; the anti-infective component of this drug is active against the following common bacterial eye pathogens: Staphylococcus aureus, S epidermidis (coagulase positive and negative), some Group A beta-hemolytic and some nonhemolytic streptococci, and some Streptococcus pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Enterobacter aerogenes, Proteus mirabilis, Morganella morganii, most Proteus vulgaris strains, Haemophilus influenzae, H aegyptius, Moraxella lacunata, Acinetobacter calcoaceticus, Klebsiella pneumoniae, and some Neisseria species
Usual Adult Dose for Iritis
Apply 1 or 2 drops into the conjunctival sac of the affected eye(s) every 4 to 6 hours; during the initial 24 to 48 hours, may increase frequency to every 1 to 2 hours
Comments:
- The frequency should be gradually decreased as warranted by improvement of clinical signs.
- Care should be taken as to not discontinue therapy prematurely.
- A maximum of 20 mL should be prescribed initially and not refilled without further evaluation.
Use: For the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or risk of bacterial ocular infection exists; the anti-infective component of this drug is active against the following common bacterial eye pathogens: Staphylococcus aureus, S epidermidis (coagulase positive and negative), some Group A beta-hemolytic and some nonhemolytic streptococci, and some Streptococcus pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Enterobacter aerogenes, Proteus mirabilis, Morganella morganii, most Proteus vulgaris strains, Haemophilus influenzae, H aegyptius, Moraxella lacunata, Acinetobacter calcoaceticus, Klebsiella pneumoniae, and some Neisseria species
Usual Adult Dose for Ocular Infection
Apply 1 or 2 drops into the conjunctival sac of the affected eye(s) every 4 to 6 hours; during the initial 24 to 48 hours, may increase frequency to every 1 to 2 hours
Comments:
- The frequency should be gradually decreased as warranted by improvement of clinical signs.
- Care should be taken as to not discontinue therapy prematurely.
- A maximum of 20 mL should be prescribed initially and not refilled without further evaluation.
Use: For the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or risk of bacterial ocular infection exists; the anti-infective component of this drug is active against the following common bacterial eye pathogens: Staphylococcus aureus, S epidermidis (coagulase positive and negative), some Group A beta-hemolytic and some nonhemolytic streptococci, and some Streptococcus pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Enterobacter aerogenes, Proteus mirabilis, Morganella morganii, most Proteus vulgaris strains, Haemophilus influenzae, H aegyptius, Moraxella lacunata, Acinetobacter calcoaceticus, Klebsiella pneumoniae, and some Neisseria species
Usual Adult Dose for Allergic Conjunctivitis
Apply 1 or 2 drops into the conjunctival sac of the affected eye(s) every 4 to 6 hours; during the initial 24 to 48 hours, may increase frequency to every 1 to 2 hours
Comments:
- The frequency should be gradually decreased as warranted by improvement of clinical signs.
- Care should be taken as to not discontinue therapy prematurely.
- A maximum of 20 mL should be prescribed initially and not refilled without further evaluation.
Use: For the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or risk of bacterial ocular infection exists; the anti-infective component of this drug is active against the following common bacterial eye pathogens: Staphylococcus aureus, S epidermidis (coagulase positive and negative), some Group A beta-hemolytic and some nonhemolytic streptococci, and some Streptococcus pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Enterobacter aerogenes, Proteus mirabilis, Morganella morganii, most Proteus vulgaris strains, Haemophilus influenzae, H aegyptius, Moraxella lacunata, Acinetobacter calcoaceticus, Klebsiella pneumoniae, and some Neisseria species
Usual Adult Dose for Bacterial Conjunctivitis
Apply 1 or 2 drops into the conjunctival sac of the affected eye(s) every 4 to 6 hours; during the initial 24 to 48 hours, may increase frequency to every 1 to 2 hours
Comments:
- The frequency should be gradually decreased as warranted by improvement of clinical signs.
- Care should be taken as to not discontinue therapy prematurely.
- A maximum of 20 mL should be prescribed initially and not refilled without further evaluation.
Use: For the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or risk of bacterial ocular infection exists; the anti-infective component of this drug is active against the following common bacterial eye pathogens: Staphylococcus aureus, S epidermidis (coagulase positive and negative), some Group A beta-hemolytic and some nonhemolytic streptococci, and some Streptococcus pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Enterobacter aerogenes, Proteus mirabilis, Morganella morganii, most Proteus vulgaris strains, Haemophilus influenzae, H aegyptius, Moraxella lacunata, Acinetobacter calcoaceticus, Klebsiella pneumoniae, and some Neisseria species
Usual Adult Dose for Keratitis
Apply 1 or 2 drops into the conjunctival sac of the affected eye(s) every 4 to 6 hours; during the initial 24 to 48 hours, may increase frequency to every 1 to 2 hours
Comments:
- The frequency should be gradually decreased as warranted by improvement of clinical signs.
- Care should be taken as to not discontinue therapy prematurely.
- A maximum of 20 mL should be prescribed initially and not refilled without further evaluation.
Use: For the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or risk of bacterial ocular infection exists; the anti-infective component of this drug is active against the following common bacterial eye pathogens: Staphylococcus aureus, S epidermidis (coagulase positive and negative), some Group A beta-hemolytic and some nonhemolytic streptococci, and some Streptococcus pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Enterobacter aerogenes, Proteus mirabilis, Morganella morganii, most Proteus vulgaris strains, Haemophilus influenzae, H aegyptius, Moraxella lacunata, Acinetobacter calcoaceticus, Klebsiella pneumoniae, and some Neisseria species
Usual Adult Dose for Cyclitis
Apply 1 or 2 drops into the conjunctival sac of the affected eye(s) every 4 to 6 hours; during the initial 24 to 48 hours, may increase frequency to every 1 to 2 hours
Comments:
- The frequency should be gradually decreased as warranted by improvement of clinical signs.
- Care should be taken as to not discontinue therapy prematurely.
- A maximum of 20 mL should be prescribed initially and not refilled without further evaluation.
Use: For the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or risk of bacterial ocular infection exists; the anti-infective component of this drug is active against the following common bacterial eye pathogens: Staphylococcus aureus, S epidermidis (coagulase positive and negative), some Group A beta-hemolytic and some nonhemolytic streptococci, and some Streptococcus pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Enterobacter aerogenes, Proteus mirabilis, Morganella morganii, most Proteus vulgaris strains, Haemophilus influenzae, H aegyptius, Moraxella lacunata, Acinetobacter calcoaceticus, Klebsiella pneumoniae, and some Neisseria species
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- For ophthalmic use only.
- Shake well before use.
Storage requirements:
- Store upright.
- Protect from freezing.
Monitoring:
- Ocular: Routinely measure intraocular pressure if this drug is used for 10 days or longer.
Patient advice:
- Avoid allowing the tip of the dropper to touch any surface as this may contaminate the suspension.
- If pain develops, redness, itching, or inflammation becomes aggravated, consult a physician.
- Avoid wearing soft contact lenses when using this drug.
More about loteprednol / tobramycin ophthalmic
- Check interactions
- Compare alternatives
- Reviews (5)
- Side effects
- During pregnancy
- Drug class: ophthalmic steroids with anti-infectives
- En español
Patient resources
- Loteprednol and tobramycin ophthalmic drug information
- Loteprednol and tobramycin (Advanced Reading)
Other brands
Professional resources
Other brands
Related treatment guides
See also:
Humira
Humira is a tumor necrosis factor blocker that is used to treat many inflammatory conditions such ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Atropine ophthalmic
Atropine ophthalmic is used for pupillary dilation, refraction, assessment, uveitis
Adalimumab
Adalimumab is used to treat plaque psoriasis, Crohn's disease, ulcerative colitis, rheumatoid ...
Bacitracin ophthalmic
Bacitracin ophthalmic is used for conjunctivitis, bacterial
Gentamicin ophthalmic
Gentamicin ophthalmic is used for conjunctivitis, bacterial
Azathioprine
Azathioprine systemic is used for atopic dermatitis, autoimmune hepatitis, behcet's disease ...
Erythromycin ophthalmic
Erythromycin ophthalmic is used for conjunctivitis, bacterial
Prednisolone ophthalmic
Prednisolone ophthalmic is used for allergies, conjunctivitis, allergic, iritis, keratitis ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.